Amneal Pharmaceuticals Inc (AMRX)

03:56 AM

Is Amneal Pharmaceuticals Inc. a good long term investmentPowerful profit generation - PrintWeekIndia

03:56 AM

12:18 PM

Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan - Investing.com Nigeria

12:18 PM

Jul 24, 2025

What analysts say about Amneal Pharmaceuticals Inc. stockFree Investment Community - Autocar Professional

Jul 24, 2025

Jul 24, 2025

Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan By Investing.com - Investing.com South Africa

Jul 24, 2025

Jul 24, 2025

What drives Amneal Pharmaceuticals Inc. stock priceConsistent double returns - Autocar Professional

Jul 24, 2025

Jul 24, 2025

Amneal Pharmaceuticals Prices $600M Senior Notes Offering - TipRanks

Jul 24, 2025

Jul 24, 2025

Why Investors Shouldn't Be Surprised By Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Low P/S - simplywall.st

Jul 24, 2025

Jul 23, 2025

Amneal Pharmaceuticals Inc. Stock Analysis and ForecastUnrivaled growth potential - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Amneal Announces Proposed Refinancing of Existing Credit - GlobeNewswire

Jul 22, 2025

Jul 21, 2025

Amneal reports 3% revenue growth in Q2, advances deleveraging By Investing.com - Investing.com India

Jul 21, 2025

Jul 21, 2025

Amneal reports 3% revenue growth in Q2, advances deleveraging - Investing.com

Jul 21, 2025

Jul 21, 2025

Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results - ADVFN Brasil

Jul 21, 2025

Jul 21, 2025

Amneal seeks to borrow $1.8 billion in new term loans, offers notes - Investing.com UK

Jul 21, 2025

Jul 21, 2025

Amneal (AMRX) targets $2.55B debt refinancing via loans & notes | AMRX SEC FilingForm 8-K - Stock Titan

Jul 21, 2025

Jul 21, 2025

Amneal Pharmaceuticals Reports Preliminary Q2 2025 Financial Results Indicating Growth and Deleveraging Efforts - Quiver Quantitative

Jul 21, 2025

Jul 21, 2025

Amneal Pharmaceuticals Unveils Massive $2.55 Billion Debt Restructuring PlanWhat's Changing - Stock Titan

Jul 21, 2025

Jul 18, 2025

Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada - The Manila Times

Jul 18, 2025

Jul 18, 2025

Thérapeutique Knight annonce le dépôt d’une nouvelle soumission réglementaire pour CREXONT® (carbidopa et lévodopa) au Canada en capsules à libération prolongée - GlobeNewswire Inc.

Jul 18, 2025

Jul 16, 2025

Parkinson's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com

Jul 16, 2025

Jul 13, 2025

Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension - MSN

Jul 13, 2025

Jul 10, 2025

Amneal to Report Second Quarter 2025 Results on August 5, 2025 - GlobeNewswire

Jul 10, 2025

Jul 09, 2025

Amneal Earnings: How to Join Q2 2025 Results Call on August 5 - Stock Titan

Jul 09, 2025

Jul 04, 2025

Riot Platforms selling more Bitfarms (BITF) - The Globe and Mail

Jul 04, 2025

Jul 02, 2025

Analysts Bullish as Amneal Pharmaceuticals, Inc. (AMRX) Director Sells Over 94K Shares - Yahoo Finance

Jul 02, 2025

Jun 30, 2025

Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Jun 30, 2025

Jun 27, 2025

Kashiv’s Xolair Biosimilar Nears US And EU Filings As Phase III Data Reports - insights.citeline.com

Jun 27, 2025

Jun 26, 2025

5 Revealing Analyst Questions From Amneal’s Q1 Earnings Call - FinancialContent

Jun 26, 2025

Jun 25, 2025

Amneal's Xolair Biosimilar Aces Phase 3 Trial, Eyes $3.9B Market Share with Q4 2025 FDA Filing - Stock Titan

Jun 25, 2025

Jun 24, 2025

Amneal Pharmaceuticals Breaks Above 200-Day Moving AverageBullish for AMRX - Nasdaq

Jun 24, 2025

Jun 19, 2025

Investing in Amneal Pharmaceuticals (NASDAQ:AMRX) three years ago would have delivered you a 157% gain - simplywall.st

Jun 19, 2025

Jun 18, 2025

Insider Sell: Gautam Patel Sells 94,906 Shares of Amneal Pharmac - GuruFocus

Jun 18, 2025

Jun 18, 2025

Insider Sell: Gautam Patel Sells 94,906 Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

Jun 18, 2025

Jun 17, 2025

Parkinson’s Disease Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal Pharma, Pharma Two B, Jazz Pharma - Barchart.com

Jun 17, 2025

Jun 17, 2025

Parkinson's Disease Market to Show Remarkable Growth Trends - openPR.com

Jun 17, 2025

Jun 13, 2025

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - Yahoo Finance

Jun 13, 2025